×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
Author Login
Peer Review
Office Work
Editor-in-Chief
Toggle navigation
Home
About Us
About Journal
Editorial Board
Publishing Ethics
Contacts Us
Advertisement
Journals
Current Issue
Archive
Collections
Most Read
Most Download
Most Cited
Email Alert
Just Accepted
Author Center
Instruction
Author Login
Download
Feedback
Journal Dynamic
中文
A Cost-Effectiveness Analysis of Lurbinectedin and Atezolizumab As First-Line Treatment for Extensive-stage Small Cell Lung Cancer in The United States
Jiang Cai-ying1, Zhang Yan-xiao2
Asia-Pacific Medical Frontiers . 2026, (
1
): 84 -96 .
